Mandalmed, Inc.
San Francisco, CA Doing business as Mandalmed Inc.
- UEI
- NPGNAQVJ3VZ7
- CAGE
- 472C9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 665 3rd St #250, San Francisco, CA 94107, USA
- Website
- mandalmed.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cell-based gene therapy for MPS IVA - project summary/abstract mucopolysaccharidosis type IVA (morquio a or MPS IVA)… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $306,872 | |
| Biologic inhibitor of galectin-3 for liver fibrosis | National Institute of Diabetes and Digestive and Kidney Diseases | $299,898 | |
| Inhibition of galectin-3 for therapy of remodeling after myocardial infarction | National Institute on Aging | $2,225,939 | |
| Protein inhibitor of galectin-3 to limit fibrosis after myocardial infarction | National Institutes of Health | $299,958 | |
| Model of the human testis for reproductive toxicology | National Institutes of Health | $250,000 |
Quick answers
What is Mandalmed, Inc.'s UEI?
Mandalmed, Inc.'s Unique Entity ID (UEI) in SAM.gov is NPGNAQVJ3VZ7.
What is Mandalmed, Inc.'s CAGE code?
Mandalmed, Inc.'s CAGE code is 472C9.
Where is Mandalmed, Inc. located?
Mandalmed, Inc.'s physical address in SAM.gov is 665 3rd St #250, San Francisco, CA 94107, USA.
Is Mandalmed, Inc. registered in SAM.gov?
Yes. Mandalmed, Inc.'s SAM.gov registration is active through September 24, 2027.
What is Mandalmed, Inc.'s most recent federal award?
Mandalmed, Inc.'s most recent federal grant award is Cell-based gene therapy for MPS IVA - project summary/abstract mucopolysaccharidosis type IVA (morquio a or MPS IVA)… (R43AR084638), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on August 1, 2024.
On GovTribe
See Mandalmed, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors